ECMO for COVID19 in Japan
Current situation of ECMO use in Japan for COVID-19 associated ARDS: second ELSO webinar focused on the use of ECLS during the SARS-CoV-2 pandemics, run on March 30th.
You may also like
Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: the RESTORE Randomized Clinical Trial
Among patients with symptomatic mild to moderate radiographic knee OA, intra-articular injection of PRP, compared with injection of saline placebo, did not result in a significant difference in symptoms or joint structure at 12 months. These findings do not support use of PRP for the management of knee OA.
Complement Suppression Drug Does Not Prevent Cognitive Decline After CABG
Treatment with pexelizumab, a monoclonal antibody against the C5 complement component, does not prevent the overall drop in cognition that can occur after coronary artery bypass grafting (CABG), new research shows.